A carregar...
Opioid system in L-DOPA-induced dyskinesia
L-3, 4-Dihydroxyphenylalanine (L-DOPA)-induced dyskinesia (LID) is a major clinical complication in the treatment of Parkinson’s disease (PD). This debilitating side effect likely reflects aberrant compensatory responses for a combination of dopaminergic neuron denervation and repeated L-DOPA admini...
Na minha lista:
| Publicado no: | Transl Neurodegener |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5240307/ https://ncbi.nlm.nih.gov/pubmed/28105331 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40035-017-0071-y |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|